Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+248,919
Put/Call ratio
3.1%
SEC-reported price per share
$2.32
Number of holders
104
Value change
+$21,039,242
Number of buys
49
Open additional details 1 more signal available
Number of sells
73
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,992,318

Security key

59045L106

Report period

Q4 2023

Institutions

104

Top holders

10

Ownership snapshot

Top reported holders of MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $24,593,154 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

EcoR1 Capital, LLC has the largest disclosed position value at $24.59M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens EcoR1 Capital, LLC's linked filing trail.
Disclosed position value Top 5
EcoR1 Capital, LLC $24.59M
Venrock Adviser, LLC $14.39M
Bain Capital Life Sciences Invest... $11M
BlackRock Finance, Inc. $10.13M
VANGUARD GROUP INC $7.86M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EcoR1 Capital, LLC
13F
Company
13F
—
denominator unverified
$24,593,154
19,364,688 shares
— 30 Sep 2023
Venrock Adviser, LLC
13F
Company
13F
—
denominator unverified
$14,386,560
11,328,000 shares
— 30 Sep 2023
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
denominator unverified
$11,002,865
8,663,673 shares
— 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$10,125,278
7,972,660 shares
— 30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$7,856,376
6,186,123 shares
— 30 Sep 2023
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$6,627,654
5,218,625 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
104
Shares
113,095,763
Rows available
104
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q4 2025 Across Filers

Q4 2025 holders
3
Q4 2023 holders
104
Holder diff
101
Investor Q4 2025 Shares Q4 2023 Shares Share Diff Share Chg % Q4 2025 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .